Aurobindo Pharma Shares Slump 1% on 8 USFDA Observations
Shares of Aurobindo Pharma Ltd were trading almost 1% lower on Monday, 8 September, after the company received eight observations from the United States Food...
Tag : Aurobindo Pharma Ltd
Aurobindo Pharma Shares Slump 2% on Securing Approval in the UK
Shares of Aurobindo Pharma Ltd were trading almost 2% lower on Tuesday, 26 August, despite its subsidiary gaining regulatory approval in the United Kingdom to...
Pharma Shares Crash Trump Issues Letter for Lowered Prices
Shares of prominent pharmaceutical companies fell substantially as investors assessed the impact of US President Trump’s letter to 17 global drug majors requesting that they...
Aurobindo Pharma Subsidiary Secures European Commission Approval
CuraTeQ Biologics, the wholly owned step-down subsidiary of Aurobindo Pharma Ltd, on 2 July announced that it has obtained marketing authorisation from the European Commission...
Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals
Shares of Biocon, Zydus Lifesciences, and Aurobindo Pharma moved higher by up to 2% after the companies announced regulatory milestones achieved in the US and...
Aurobindo Pharma Shares Surge 4% as Arm Secures Final USFDA Approval
Share of Aurobindo Pharma Ltd surged 4% on 23 April after the company’s wholly-owned subsidiary announced securing final approval from the US Food and Drug...
Aurobindo Pharma Gets USFDA Green Light for Generic Xarelto
Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban Tablets USP, 2.5mg, which is the...
Aurobindo Pharma Arm Completes Phase 1 Trials of New Bone Medicine
Pharmaceutical major Aurobindo Pharma Ltd, on 10 April, announced that its subsidiary, CuraTeQ Biologics, has successfully completed the phase 1 Trial of its new bone...
Aurobindo Pharma Falls 3% After US FDA Flags Issues at AP Facility
Shares of Aurobindo Pharma Ltd fell 3% after touching a day’s high of Rs 1,138.05 on 19th February, following the US FDA’s completion of a...
Aurobindo Pharma Shares Slump 2% Despite Telangana Secures VAI Status
Shares of Aurobindo Pharma Ltd slumped 2% on 28 January despite the company declaring that the Telangana active pharmaceutical ingredient (API) factory owned by one...